Search Results 401-410 of 17218 for SC

1. Safety, Efficacy And Tolerability Of Ianalumab Versus Placebo, Combination With SoC Therapy, In Participants With Active Lupus Nephritis - Mayo Clinic

   About this study. The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks ...

2. Publications - Vinayak Nagaraja, M.B.B.S. - Mayo Clinic

   Khatri Jai, Young Laura, Nagaraja Vinayak. Complex PCI Cath lab digest. 2020. Nagaraja V, Kapadia SR, Miyasaka R, Harb SC, Krishnaswamy A. Contemporary review ...

3. Publications - Bismarck S. Bisono Garcia, M.D. - Mayo Clinic

   Mena Lora AJ, Rojas-Fermin R, Bisono B, Almonte M, Bleasdale SC. A nationwide survey of antimicrobial dispensation practices in pharmacies and bodegas in ...

4. Scoliosis - Symptoms and causes - Mayo Clinic

   This side-to-side curve of the spine happens most often during the growth spurt after age 10. Treatment may include bracing or surgery.

5. Publications - Michael Gharacholou, M.D., M.S. - Mayo Clinic

   ... SC. Characteristics and outcomes of patients with peripheral artery disease undergoing endovascular revascularization: A community hospital perspective ...

6. Judy C. Boughey, M.D. - Doctors and Medical Staff - Mayo Clinic

   ... South Carolina Chapter of the ACS, Charleston, SC. 2000. First Place Award, Resident Paper CompetitionSC-ACS Committee on Trauma, Greenville, SC. 1995. Henry ...

7. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   ... SC dose at Week 2 [or one 80 mg SC dose at Baseline, followed by one 40 mg SC dose at Week 2, in countries where this dosing regimen is approved]); OR; At ...

8. Publications - Steven E. Schild, M.D. - Mayo Clinic

   ... SC, Yau E, Gregory KM, Hughes M. NCCN Guidelines(R) Insights: Non-Small Cell Lung Cancer, Version 2.2023. J Natl Compr Canc Netw. 2023 Apr; 21 (4):340-350

9. Nonalcoholic Clinical Trials - Mayo Clinic Research

   ... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...

10. Nonalcoholic Steatohepatitis Clinical Trials - Mayo Clinic Research

    ... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...